This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
EA Bolyard ,
Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infection Control and Hospital Epidemiology
1998; 19: 407–463.
S Asari ,
Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan. American Journal of Infection Control
2003; 31: 157–162.
S Vagholkar ,
Healthcare workers and immunity to infectious diseases. Australian and New Zealand Journal of Public Health
2008; 32: 367–371.
U Fedeli , C Zanetti , B Saia . Susceptibility of healthcare workers to measles, mumps rubella and varicella. Journal of Hospital Infection
2002; 51: 133–135.
A Celikbas ,
Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
American Journal of Infection Control
2006; 34: 583–587.
MA Almuneef ,
Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Infection Control and Hospital Epidemiology
2006; 27: 1178–1183.
C Sadzot-Delvaux ,
Varicella vaccination in Japan, South Korea, and Europe. Journal of Infectious Diseases
2008; 197 (Suppl. 2): 185–190.
A Kaetsu ,
An outbreak of measles in Saitama City in 2007. What is the vaccination strategy to eliminate measles in Japan?
Journal of Infection and Chemotherapy
2008; 14: 291–295.
HD Clifford ,
Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique. Vaccine
2012; 30: 6180–6185.
H de Melker ,
The seroepidemiology of measles in Western Europe. Epidemiology and Infection
2001; 126: 249–259.
IJ Amanna , NE Carlson , MK Slifka . Duration of humoral immunity to common viral and vaccine antigens. New England Journal of Medicine
2007; 357: 1903–1915.
MS Lee ,
Protective titres of measles neutralising antibody. Journal of Medical Virology
2000; 62: 511–517.
P Tharmaphornpilas ,
Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme. Journal of Health, Population and Nutrition
2009; 27: 80–86.
LP Skendzel . Rubella immunity. Defining the level of protective antibody. American Journal of Clinical Pathology
1996; 106: 170–174.
L Matter , K Kogelschatz , D Germann . Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations. Journal of Infectious Diseases
1997; 175: 749–755.
JL Backhouse ,
Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus. Clinical and Vaccine Immunology
2006; 13: 764–767.
I Davidkin ,
Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. Journal of Infectious Diseases
2008; 197: 950–956.